This post is also available in: Swedish
Elos Medtech AB’s Board of Directors comprises six members elected by the Annual General Meeting.
In accordance with the provisions of the Swedish Companies Act, the Board establishes a work procedure each year containing instructions regarding the distribution of work within the Board, distribution of responsibility between the Board and the President and the financial reporting to the Board. During a fiscal year, in addition to the statutory meeting, the Board has six ordinary meetings. At these meetings, the Board addresses points specified for each meeting such as the current status of business, the budget, year-end financial statements and interim reports. In addition, issues such as investments, structural and organizations changes are addressed.
Within the Board, there is a Remuneration Committee and an Audit Committee. The Remuneration Committee discusses and decides on remunerations to the President and to the senior executives who report directly to the President. The Audit Committee deals with questions concerning accounting, internal controls and IT security.
Corporate Governance Code
Elos Medtech AB is a Swedish limited liability company, whose Series B share is listed on the NASDAQ Stockholm AB Small Cap. Corporate governance at Elos Medtech is based on Swedish legislation and the listing agreement with NASDAQ Stockholm AB.
Elos Medtech is governed via the general meetings of shareholders, the Board of Directors and the President in accordance with the Swedish Companies Act and the company’s Articles of Association and rules of procedure.
From 1 July 2008, it is good practice in the stock market for all companies whose shares are registered for trading on a regulated market to apply the Swedish Corporate Governance Code. Such application has been introduced at Elos Medtech AB.
Nomination Committee 2020
The Nomination Committee for the Annual General Meeting 2020:
The three largest shareholders are represented by Thomas Öster, Ulf Runmarker and Bo Nilsson.
Representatives of the other shareholders are Ulf Hedlundh, Svolder AB, and Bengt Belfrage, Nordea Investment Funds, who is also the Chairman of the Nomination Committee. Yvonne Mårtensson, Chairman of the Board is adjunct to the Nomination Committee.
Shareholders who wish to submit proposals to the Nomination Committee should e-mail to firstname.lastname@example.org or send mail to:
The Nomination Committee, Elos Medtech AB, Torsgatan 5B, 411 04 Gothenburg, Sweden.